CD202b
Aliases: | CD202B, GLC3E, TIE-2, TIE2, VMCM, VMCM1 |
---|---|
Other: | angiopoietin-1 receptor|TEK tyrosine kinase, endothelial|endothelial tyrosine kinase|tunica interna endothelial cell kinase|tyrosine kinase with Ig and EGF homology domains-2|tyrosine-protein kinase receptor TEK|tyrosine-protein kinase receptor TIE-2 |
This gene encodes a receptor that belongs to the protein tyrosine kinase Tie2 family. The encoded protein possesses a unique extracellular region that contains two immunoglobulin-like domains, three epidermal growth factor (EGF)-like domains and three fibronectin type III repeats. The ligand angiopoietin-1 binds to this receptor and mediates a signaling pathway that functions in embryonic vascu... see more
CF594
Common Laser: | 594 |
---|---|
Common Filter: | 610/20 |
Excitation Peak: | 593 |
Emission Peak: | 614 |
CF®594 from Biotium is a fluorophore with an excitation peak at 593 nm and an emission peak at 614 nm. It can be useful in both fluorescence microscopy and flow cytometry. It is spectrally similar to Alexa Fluor™ 594, DyLight™ 594 and Texas Red. However, in flow cytometry, PE-CF®594 and PE-Dazzle 594 are superior alternatives. In microscopy, CF®594 has been validated in STED and 2-Photon micros... see more
Popular CD202b CF594 Antibodies
Company / SKU |
Applications | Marker / Reactivity |
Host / Isotype / Clone |
Size / Price |
Details | |
---|---|---|---|---|---|---|
Biorbyt orb395794-CF594 |
ICC,IF | CD202b Human,Rat |
Rabbit IgG |
100 ug $459 |
Details | |
Biorbyt orb11480-CF594 |
ICC,IF | CD202b Human,Mouse,Rat |
Rabbit IgG |
100 ug $479 |
Details | |
Biorbyt orb500912-CF594 |
ICC,IF | CD202b Human,Mouse,Rat |
Rabbit IgG |
100 ug $479 |
Details | |
Biorbyt orb315724-CF594 |
ICC,IF | CD202b Human,Mouse,Zebrafish |
Rabbit IgG |
100 &mu $449 |
Details | |
Biorbyt orb523484-CF594 |
ICC,IF | CD202b Human,Mouse |
Rabbit IgG |
100 &mu $575 |
Details | |
Biorbyt orb523485-CF594 |
ICC,IF | CD202b Human,Mouse |
Rabbit IgG |
100 &mu $575 |
Details | |
Browse CD202b / CF594 antibodies. |